HP06-2021SVP | Supply and Delivery of Small Volume Parenterals and Insulin Devices for the period 1 May 2021 to 30 April 2024 | 01 May 2021 | HP06-2021SVP Contract Circular 29 March 2021 ↓ | | |
HP01-2019TB | Supply and Delivery of Anti-Tuberculosis Medicines to the Department of Health for the period 01 October 2019 to September 2021
| 01 October 2019 | HP01-2019TB Contract Circular Final 20 Sept 2019 ↓ | Index HP01-2019TB April 2021 ↓ | HP01-2019TB Add 1 Price Reduction ↓
HP01-2019TB Add 2 – 8 CPA Effective 1 April 2020 ↓
HP01-2019TB Add 9 -14 CPA Effective 1 May 2020 ↓
HP01-2019TB Add 15 – 22 CPA Effective 1 June 2020 ↓
HP01-2019TB Add 23 – 27 CPA Effective 1 July 2020 ↓
HP01-2019TB Add 28 – 33 CPA Effective 1 October 2020 ↓
HP01-2019TB Add 34 – 39 CPA Effective 1 January 2021 ↓
HP01-2019TB Add 40 – 46 CPA Effective 1 April 2021 ↓ |
HP02-2019AI | Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) for the period 1 October 2019 to 30 September 2021 | 01 October 2019 | HP02-2019AI Contract Circular Final 23 Sept 2019 ↓ | Index HP02-2019AI April 2021 ↓ | HP02-2019AI Add 1 Price Reduction ↓
HP02-2019AI Add 2 – 15 CPA Effective 1 April 2020 ↓
HP02-2019AI Add 16 – 34 CPA Effective 1 May 2020 ↓
HP02-2019AI Add 35 – 44 CPA Effective 1 June 2020 ↓
HP02-2019AI Add 45 – 62 CPA Effective 1 July 2020 ↓
HP02-2019AI Add 63 – 82 CPA Effective 1 October 2020 ↓
HP02-2019AI Add 83 – 102 Effective 1 January 2021 ↓
HP02-2019AI Add 103 – 122 CPA Effective 1 April 2021 ↓ |
HP02-2019AI/01 | Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) for the period ending 30 September 2021 | 22 January 2020 | HP02-2019AI/01 Contract Circular 23 Jan 2020_1 ↓ | Index HP02-2019AI-01 ↓ | HP02-2019AI_01 Add 1 Effective 1 June 2020 ↓
HP02-2019AI_01 Add 2 Effective 1 July 2020 ↓
HP02-2019AI_01 Add 3 Effective 1 October 2020 ↓
HP02-2019AI_01 Add 4 Effective 1 January 2021 ↓
|
HP02-2019AI/02 | Supply and Delivery of Anti-Infective Medicines (Antibiotics, Antifungal, Antiprotozoal and Antiviral Agents) for the period ending 30 September 2021 | 30 October 2020 | HP02-2019AI_02 Contract Circular 6 Jan 2021 ↓ | | |
HP03-2020CHM
| Supply and Delivery of contraceptives and hormone modulating agents for the period 1 October 2020 to 30 September 2023. | 01 October 2020 | HP03-2020CHM Contract Circular 18 Aug 2020 ↓ | HP03-2020CHM Index ↓ | HP03-2020CHM Add 1 CPA Effective 1 October 2020 ↓
HP03-2020CHM Add 2 CPA Effective 1 February 2021 ↓
|
HP03-2020CHM/01
| Supply and Delivery of contraceptives and hormone modulating agents for the period ending 30 September 2023.
| 28 January 2021 | HP03-2020CHM_01 Contract Circular 28 Jan 2021 ↓ | | |
HP04-2020ONC
| Supply and Delivery of Oncology and Immunological agents to the Department of health for the period 01 July 2020 to 30 June 2022
| 01 July 2020 | HP04-2020ONC Contract Circular 20200421 ↓ | HP04-2020ONC INDEX ↓ | HP04-2020ONC Add 1 – 5 CPA Effective 1 July 2020 ↓
HP04-2020ONC Add 6 – 10 CPA Effective 1 November 2020 ↓
HP04-2020ONC Add 11 Price vs Pack size ↓
HP04-2020ONC Add 12 – 16 CPA Effective 1 February 2021 ↓ |
HP04-2020ONC/01 | Supply and Delivery of Oncology and Immunological agents to the Department of health for the period ending 30 June 2022 | 30 October 2020 | HP04-2020ONC_01 Contract Circular 06 Jan 2021 ↓ | HP04-2020ONC_01 INDEX ↓ | HP04-2020ONC_01 Add 1 Estimate Correction ↓
HP04-2020ONC_01 Add 2 CPA Effective 1 February 2021 ↓
|
RT291-2018 | HP05
| Supply and Delivery of Diagnostic Agents and Contrast Media to the Department of Health for the period 01 July 202018 to 30 June 2021
| 01 July 2018 | RT291-2018 Contract Circular ↓ | RT291-2018 Index April 2021 ↓ | RT291-2018 Add 1 CPA Effective 1 January 2020 ↓
RT291-2018 Add 2 CPA Effective 1 April 2020 ↓
RT291-2018 Add 3 – 5 CPA Effective 1 May 2020 ↓
RT291-2018 Add 6 CPA Effective 1 October 2020 ↓
RT291-2018 Add 7 – 9 CPA Effective 1 January 2021 ↓
RT291-2018 Add 10 – 12 CPA Effective 1 April 2021 ↓ |
RT297-2019 | HP06
| Supply and Delivery of Small Volume Parenterals and Insulin Devices for the 1 May 2019 to 30 April 2021
| 01 May 2019 | RT297-2019 Contract Circular ↓ | RT297-2019_Index ↓ | RT297-2019 Add 1 – 8 Treasury ↓
RT297-2019 Add 9 – 12 CPA Effective 1 September 2019 ↓
RT297-2019 Add 13 – 17 CPA Effective 1 January 2020 ↓
↓
RT297-2019 Add 18 – 24 CPA Effective 1 April 2020 ↓
RT297-2019 Add 25 – 38 CPA Effective 1 May 2020 ↓
RT297-2019 Add 39 – 44 CPA Effective 1 June 2020 ↓
RT297-2019 Add 45 – 55 CPA Effective 1 July 2020 ↓
RT297-2019 Add 56 NSN Replacement ↓
RT297-2019 Add 57 – 68 CPA Effective 1 October 2020 ↓
RT297-2019 Add 69 – 83 CPA Effective 1 January 2021 ↓ |
HP06-2019SVP/01
| Supply and Delivery of Small Volume Parenterals and Insulin Devices for the period ending 30 April 2021
| 22 January 2020 | HP06-2019SVP-01 Contract Circular 2 Jan 2020_1 ↓ | HP06-2019SVP-01 Index ↓ | HP06-2019SVP_01 Add 1 CPA Effective 1 April 2020 ↓
HP06-2019SVP_01 Add 2 – 4 CPA Effective 1 May 2020 ↓
HP06-2019SVP_01 Add 7 – 10 CPA Effective 1 July 2020 ↓
HP06-2019SVP_01 Add 11 – 14 Effective 1 October 2020 ↓
HP06-2019SVP_01 Add 15 – 20 Effective 1 January 2021 ↓ |
HP07-2020DAI
| Supply and Delivery of Drops, Aerosols and Inhaled Medicines to the Department of health for the period 01 July 2020 to 30 June 2023
| 01 July 2020 | HP07-2020DAI CONTRACT CIRCULAR ↓ | HP07-2020DAI Index ↓ | HP07-2020DAI Add 1 Replace CC version 1 ↓
HP07-2020DAI Add 2 – 9 CPA Effective 1 July 2020 ↓
HP07-2020DAI Add 10 NSN Replacement ↓
HP07-2020DAI Add 11 NSN Replacement Salbutamol ↓
HP07-2020DAI Add 12 – 21 CPA Effective 1 November 2020 ↓
HP07-2020DAI Add 22 – 31 CPA Effective 1 February 2021 ↓
|
HP07-2020DAI/01
| Supply and Delivery of Drops, Aerosols and Inhaled Medicines to the Department of health for the period ending 30 June 2023
| 30 October 2020 | HP07-2020DAI_01 Contract Circular 02 Nov 2020 ↓ | HP07-2020DAI_01 Index ↓ | HP07-2020DAI_01 Add 1 NSN Replacement Beclometasone (2) ↓
HP07-2020DAI_01 Add 2 CPA Effective 1 February 2021 ↓ |
HP08-2020SSP
| Supply and Delivery of Semi-Solid Dosage Forms and Powders to the Department of health for the period 01 July 2020 to 30 June 2023
| 01 July 2020 | HP08-2020SSP Contract Circular 24 June 2020 V2 ↓ | HP08-2020SSP INDEX ↓ | HP08-2020SSP Add 1 – 7 CPA Effective 1 July 2020 ↓
HP08-2020SSP Add 8 Brand Name Change ↓
HP08-2020SSP Add 9 Contract Circular 24 June 2020 V2 ↓
HP08-2020SSP Add 10 – 16 CPA Effective 1 November 2020 ↓
HP08-2020SSP Add 17 Item Cancellation ↓
HP08-2020SSP Add 18 NSN Replacment ↓
HP08-2020SSP Add 19 – 26 CPA Effective 1 February 2021 ↓
|
HP08-2020SSP/01
| Supply and Delivery of Semi-Solid Dosage Forms and Powders to the Department of health for the period ending 30 June 2023
| 30 October 2020 | HP08-2020SSP_01 Contract Circular ↓ | | |
RT289-2019 | HP09
| Supply and Delivery of Solid Dosage Forms for the period 1 May 2019 to 30 April 2021
| 01 May 2019 | RT289-2019 Contract Circular ↓ | RT289-2019 Index ↓ | RT289-2019 Add 1 Pharmacare Price correction ↓
RT289-2019 Add 2 Pharmacare Price correction ↓
RT289-2019 Add 3 Correction of Split Percentage ↓
RT289-2019 Add 4 – 15 CPA Effective 1 October 2019 ↓
RT289-2019 Add 16 – 23 CPA Effective 1 January 2020 ↓
RT289-2019 Add 24 Correction ↓
RT289-2019 Add 25 – 38 CPA Effective 1 April 2020 ↓
RT289-2019 Add 39 Price Reduction ↓
RT289-2019 Add 40 Cancellation of Item ↓
RT289-2019 Add 41 – 60 CPA Effective 1 May 2020 ↓
RT289-2019 Add 61 – 69 CPA Effective 1 June 2020 ↓
RT289-2019 Add 70 – 87 CPA Effective 1 July 2020 ↓
RT289-2019 Add 88 – 108 CPA Effective 1 October 2020 ↓
RT289-2019 Add 109 – 131 CPA Effective 1 January 2021 ↓
|
HP09-2019SD/01
| Supply and Delivery of Solid Dosage Forms for the period ending 30 April 2021
| 12 March 2020 | HP09-2019SD_01 Contract Circular 12 March 2020 ↓ | HP09-2019SD_01 INDEX ↓ | HP09-2019SD_01 Add 1 – 4 CPA Effective 1 May 2020 ↓
HP09-2019SD_01 Add 5 – 7 CPA Effective 1 June 2020 ↓
HP09-2019SD_01 Add 8 – 12 CPA Effective 1 July 2020 ↓
HP09-2019SD_01 Add 13 – 18 CPA Effective 1 October 2020 ↓
HP09-2019SD_01 Add 19 – 24 CPA Effective 1 January 2021 ↓ |
HP09-2021SD
| Supply and Delivery of Solid Dosage Forms for the period 1 May 2021 to 30 April 2023
| 01 May 2021 | HP09-2021SD Contract Circular 24 Feb 2021 Page Break Amendment ↓ | | |
HP10-2021BIO
| Supply and Delivery of Small Biological Preparations to the Department of Health for the period 1 January 2021 to 31 December 2022
| 01 January 2021 | HP10-2021BIO Contract Circular 03 Nov 2020 ↓ | HP10-2021BIO_Index ↓ | HP10-2021BIO Add 1 Revised Contract Circular 12 Nov 2020 ↓
HP10-2021BIO Add 2 Contract Circular Replacement 28 Dec 2020 ↓
↓
↓ |
HP11-2020LVP
| Supply and Delivery of Large Volume Parenterals to the Department of Health for the period 01 October 2020 to 30 September 2023
| 01 October 2020 | HP11-2020LVP Contract Circular ↓ | HP11-2020LVP_Index ↓ | HP11-2020LVP Add 1 – 2 CPA Effective 1 October 2020 ↓
HP11-2020LVP Add 3 – 4 CPA Effective 1 February 2021 ↓ |
HP12-2020LQ
| Supply and Delivery of Pharmaceutical Liquids, Alcohol, Ether, Gycerine and Methylated Spirits to the Department of Health for the period 01 October 2020 to 30 September 2023
| 01 October 2020 | HP12-2020LQ Contract Circular Final 30 July 2020_V1 ↓ | HP12-2020LQ Index ↓ | HP12-2020LQ Add 1 Contract Circular Version 2 Add 1 ↓
HP12-2020LQ Add 2 Revised Contract Circular ↓
HP12-2020LQ Add 3 CPA Effective 9 November 2020 ↓
HP12-2020LQ Add 4 NSN Replacement ↓ |
HP12-2020LQ/01
| Supply and Delivery of Pharmaceutical Liquids, Alcohol, Ether, Gycerine and Methylated Spirits to the Department of Health for the period ending 30 September 2023
| 19 February 2021 | HP12-2020LQ_01 Contract Circular 19 February 2021 ↓ | | |
RT71-2019 | HP13
| Supply and Delivery of Anti-Retroviral Medicines to The Department of Health for the period 01 July 2019 to 30 June 2022
| 01 July 2019 | RT71-2019 Contract Circular ↓ | RT71-2019 Index April 2021 ↓ | RT71-2019 Add 1 Treasury Addendum ↓
RT71-2019 Add 2 – 8 CPA Effective 1 October 2019 ↓
RT71-2019 Add 9_Ceding of Contracted Items ↓
RT71-2019 Add 10 Correction on pack size for Janssen ↓
RT71-2019 Add 11 – 18 CPA Effective 1 January 2020 ↓
RT71-2019 Add 19 Item Cancellation Aurobindo ↓
RT71-2019 Add 20 Item Cancellation Hetero Drugs ↓
RT71-2019 Add 21 – 30 CPA Effective 1 April 2020 ↓
RT71-2019 Add 31 – 38 Blank ↓
RT71-2019 Add 39 Item Cancellation Mylan ↓
RT71-2019 Add 40 Item Cancellation Macleods ↓
RT71-2019 Add 41 – 51 CPA Effective 1 May 2020 ↓
RT71-2019 Add 52 Replacement Abbvie ↓
RT71-2019 Add 53 Revised MOQ’s Janssen ↓
RT71-2019 Add 54 – 61 CPA Effective 1 June 2020 ↓
RT71-2019 Add 62 – 71 CPA Effective 1 July 2020 ↓
RT71-2019 Add 72 – 81 CPA Effective 1 October 2020 ↓
RT71-2019 Add 82 Cancelled Addenda ↓
RT71-2019 Add 83 Brand Name Change Innovata ↓
RT71-2019 Add 84 CPA Effective 7 December 2020 ↓
RT71-2019 Add 85 – 95 CPA Effective 1 January 2021 ↓
RT71-2019 Add 96 – 105 CPA Effective 1 April 2021 ↓ |
HP13-2019ARV/01
| Supply and Delivery of Anti-Retroviral Medicines to The Department of Health for the period ending 30 June 2022
| 19 February 2020 | HP13-2019ARV_01 Contract Circular Version 2 12 March 2020 ↓
HP13-2019ARV_01 Contract Circular 20 February 2020 ↓ | HP13-2019ARV-01 2019 Index April 2021 ↓ | HP13-2019ARV_01 Add 1 Award Item & Cancellation Hetero Drugs ↓
HP13-2019ARV_01 Add 2 Award Item & Cancellation Aurobindo ↓
HP13-2019ARV_01 Add 3 Date Correction Hetero Drugs ↓
HP13-2019ARV_01 Add 4 – 5 CPA Effective 1 April 2020 ↓
HP13-2019ARV_01 Add 6 Award item & Cancellation ABBVIE ↓
HP13-2019ARV_01 Add 7 Award item & Cancellation Macleods ↓
HP13-2019ARV_01 Add 8 Volume Correction ↓
HP13-2019ARV_01 Add 9 – 12 CPA Effective 1 May 2020 ↓
HP13-2019ARV_01 Add 13 – 15 CPA RT71 Effective 1 May 2020 ↓
HP13-2019ARV_01 Add 16 Correction ABBVIE ↓
HP13-2019ARV_01 Add 17 – 18 CPA Effective 1 June 2020 ↓
HP13-2019ARV_01 Add 19 – 21 CPA RT71 Effective 1 June 2020 ↓
HP13-2019ARV_01 Add 22 – 24 CPA Effective 1 July 2020 ↓
HP13-2019ARV_01 Add 25 – 26 CPA RT71 Effective 1 July 2020 ↓
HP13-2019ARV_01 Add 27 – 28 CPA RT71 Effective 1 October 2020 ↓
HP13-2019ARV_01 Add 29 – 31 CPA Effective 1 October 2020 ↓
HP13-2019ARV_01 Add 32 Revised Contract Circular ↓
HP13-2019ARV_01 Add 33 – 35 CPA Effective 1 January 2021 ↓
HP13-2019ARV_01 Add 36 – 37 CPA RT71 Effective 1 January 2021 ↓
HP13-2019ARV_01 Add 38 – 39 CPA Effective 1 April 2021 ↓
|
HP16-2020EPI
| Supply and Delivery of Vaccines used in the Expanded programme on immunisation (EPI) for the period 1 July 2020 to 31 December 2023
| 01 July 2020 | HP16-2020EPI Contract Circular 18 Nov 2019 ↓ | HP16-2020EPI INDEX April 2021 ↓ | HP16-2020EPI Add 1 – 2 CPA Effective 1 July 2020 ↓
HP16-2020EPI Add 3 NSN Replacement ↓
HP16-2020EPI Add 4 – 5 CPA Effective 1 October 2020 ↓
HP16-2020EPI Add 6 – 7 CPA Effective Effective 1 January 2021 ↓
HP16-2020EPI Add 8 -9 CPA Effective 1 April 2021 ↓ |
HP16-2020EPI/01
| Supply and Delivery of Vaccines used in the Expanded programme on immunisation (EPI) for the period ending 31 December 2023
| 01 July 2020 | HP16-2020EPI_01 Contract Circular 20 May 2020 ↓ | HP16-2020EPI-01 INDEX April 2021 ↓ | HP16-2020EPI_01 Add 1 CPA Effective 1 July 2020 ↓
HP16-2020_01 Add 2 CPA Effective 1 October 2020 ↓
HP16-2020EPI_01 Add 3 – 4 CPA Effective 1 January 2021 ↓
HP16-2020EPI_01 Add 5 CPA effective 1 April 2021 ↓
|
| | | ↓ | ↓ | ↓
↓
↓
↓ |